Previous reports, including ours, showed that ZHX2 represses HCC oncogenes, such as AFP, GPC3, cyclin A/cyclin E and MDR1, which are involved in many biological processes of HCC development, including cell proliferation, cell migration and chemoresistance [7, 8, 10, 34]. Here, AFP is linked to hepatocellular carcinoma.